Zachary McMahon

Co-Founder & CEO | LUCID

Zach McMahon is the Co-Founder of LUCID. He led the company to its first pharma partnership to develop a DTx for Alzheimer’s, drawing on his background as a biotech and digital health consultant at ZS Associates, where he facilitated bringing new health products to market. As CEO, Zach led LUCID in securing seed funding (Q3 ’22), winning the Longitudinal Prize on Dementia, and receiving FDA Authorization for ResonanceRx. Zach also holds an MBA with honours from the University of Toronto.